A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)

NCT01235728 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Plaque Psoriasis

Interventions

DRUG: MK-0873 2% Cream
DRUG: MK-0873 vehicle (placebo) Cream
DRUG: Calcitriol Cream

Sponsor

Merck Sharp & Dohme LLC